Fine-tuned structural modifications enable specific drug design against multidrug-resistant pathogens.

In this issue of Structure, Krah et al.1 present a comprehensive study combining molecular dynamics (MD) simulations, free-energy calculations, and in vivo mutagenesis experiments to investigate how water molecules interact with the F1FO-ATP synthase c-ring domain. Their findings highlight the potential of this bacterial enzyme as a drug target.